Recruiting OBSERVATIONAL NCT05851053

Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study (BLOC-II)

Sponsor: University Medical Center Groningen

Conditions Cardiotoxicity Heart Failure Neoplasm, Breast Ventricular Dysfunction

Updated 4 times since 2023 Last updated: May 28, 2024 Started: Sep 1, 2022 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiotoxicity and Heart Failure and is currently actively recruiting participants. University Medical Center Groningen leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2024 — Jul 2024 [monthly]

Recruiting
Jun 2023 — Jun 2024 [monthly]

Recruiting

First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center Groningen
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands